Anti-septic activity of α-cubebenoate isolated from Schisandra chinensis
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Sepsis is a life-threatening, infectious, systemic inflammatory disease. In this study, we investigated the therapeutic effect of α-cubebenoate, a novel compound isolated from Schisandra chinensis against polymicrobial sepsis in a cecal ligation and puncture (CLP) experimental model. Administration of α-cubebenoate strongly enhanced survival in the CLP model. α-cubebenoate administration also markedly blocked CLP-induced lung inflammation and increased bactericidal activity by enhancing phagocytic activity and hydrogen peroxide generation in mouse bone marrow-derived macrophages and neutrophils. Expression of two important inflammatory cytokines, IL-1β and IL-6, was strongly increased in the CLP model, and this was dramatically blocked by α-cubebenoate. Lymphocyte apoptosis and caspase-3 activation, which are associated with immune paralysis during sepsis, were markedly attenuated by α-cubebenoate. Taken together, our findings indicate that α-cubebenoate, a natural compound isolated from Schisandra chinensis, is a powerful potential anti-septic agent.
Abstract
Sepsis is a life-threatening, infectious, systemic inflammatory disease. In this study, we investigated the therapeutic effect of α-cubebenoate, a novel compound isolated from Schisandra chinensis against polymicrobial sepsis in a cecal ligation and puncture (CLP) experimental model. Administration of α-cubebenoate strongly enhanced survival in the CLP model. α-cubebenoate administration also markedly blocked CLP-induced lung inflammation and increased bactericidal activity by enhancing phagocytic activity and hydrogen peroxide generation in mouse bone marrow-derived macrophages and neutrophils. Expression of two important inflammatory cytokines, IL-1β and IL-6, was strongly increased in the CLP model, and this was dramatically blocked by α-cubebenoate. Lymphocyte apoptosis and caspase-3 activation, which are associated with immune paralysis during sepsis, were markedly attenuated by α-cubebenoate. Taken together, our findings indicate that α-cubebenoate, a natural compound isolated from Schisandra chinensis, is a powerful potential anti-septic agent.
참고문헌 (23)
- Bosmann M, "The inflammatory response in sepsis", Trends Immunol, 34, pp.129~136 (2013)
- Kumar G, "Nationwide trends of severe sepsis in the 21st century (2000-2007)", Chest, 140, pp.1223~1231 (2000)
- Coopersmith CM, "A comparison of critical care research funding and the financial burden of critical illness in the United States", Crit Care Med, 40, pp.1072~1079 (2012)
- Hotchkiss RS, "Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy", Nat Rev Immunol, 13, pp.862~874 (2013)
- Wiersinga WJ, "Host innate immune responses to sepsis", Virulence, 5, pp.36~44 (2014)
- Mayadas TN, "The multifaceted functions of neutrophils", Annu Rev Pathol, 9, pp.181~218 (2014)
- Riedemann NC, "Novel strategies for the treatment of sepsis", Nat Med, 9, pp.517~524 (2003)
- Choi YW, "Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis:structure-antioxidant activity relationships of dibenzocyclooctadiene lignans", J Nat Prod, 69, pp.356~359 (2006)
- Chen DF, "Interiotherins C and D, two new lignans from Kadsura interior and antitumor-promoting effects of related neolignans on Epstein-Barr virus activation", J Nat Prod, 65, pp.1242~1245 (2002)
- Yasukawa K, "Gomisin A inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin", Oncology, 49, pp.68~71 (1992)
- Kang S, "Identification of a novel anti-inflammatory compound, α-cubebenoate from Schisandra chinensis", J Ethnopharmacol, 153, pp.242~249 (2014)
- Kim SD, "Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis", Am J Respir Crit Care Med, 184, pp.243~251 (2011)
- Kim SD, "The agonists of formyl peptide receptors prevent development of severe sepsis after microbial infection", J Immunol, 185, pp.4302~4310 (2010)
- Simard JC, "Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis", J Immunol, 186, pp.3622~3631 (2011)
- Angus DC, "Severe sepsis and septic shock", N Engl J Med, 369, pp.840~851 (2013)
- Hotchkiss RS, "The pathophysiology and treatment of sepsis", N Engl J Med, 348, pp.138~150 (2003)
- Caamaño J, "NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions", Clin Microbiol Rev, 15, pp.414~429 (2002)
- Andreakos E, "Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal", TIRAP, 2004, pp.103, 2229~2237
- Kretz-Remy C, "Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression", J Cell Biol, 133, pp.1083~1093 (1996)
- Stearns-Kurosawa DJ, "The pathogenesis of sepsis", Annu Rev Pathol, 6, pp.19~48 (2011)
- Wesche DE, "Leukocyte apoptosis and its significance in sepsis and shock", J Leukoc Biol, 78, pp.325~337 (2005)
- Oberholzer C, "Apoptosis in sepsis: a new target for therapeutic exploration", FASEB J, 15, pp.879~892 (2001)
- ProCESS Investigators, "A randomized trial of protocol-based care for early septic shock", N Engl J Med, 370, pp.1683~1693 (2014)